# GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells

**Authors:** Diana Crisan, Susanne Schatz, Heidi Hainzl, Fang Zhao, Annette Paschen, Maria Crisan, Adrian Baican, Karin Scharffetter-Kochanek, Abhijit Basu

PMC · DOI: 10.18632/oncotarget.28711 · Oncotarget · 2025-04-04

## Full-text entities

- **Genes:** GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}
- **Diseases:** melanoma (MESH:D008545)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11970936/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11970936/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC11970936/full.md

---
Source: https://tomesphere.com/paper/PMC11970936